Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Substance P-Induced Migraine Attacks Without Aura
NCT06959004Recruiting
- Sponsor
- Dansk Hovedpinecenter
- Start
- May 2025
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of substance p in migraine, sponsored by Dansk Hovedpinecenter. Primary endpoint: Incidence of migraine attacks without aura at 12 hours. Started May 2025; status: recruiting.
02
Drugs
substance p
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06959004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06959004.